1. Home
  2. IIIN vs KALV Comparison

IIIN vs KALV Comparison

Compare IIIN & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IIIN

Insteel Industries Inc.

HOLD

Current Price

$30.57

Market Cap

739.2M

Sector

Industrials

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$17.00

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIIN
KALV
Founded
1953
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
739.2M
757.7M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
IIIN
KALV
Price
$30.57
$17.00
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$30.00
AVG Volume (30 Days)
103.2K
761.7K
Earning Date
04-16-2026
05-09-2026
Dividend Yield
3.59%
N/A
EPS Growth
112.12
N/A
EPS
0.39
N/A
Revenue
$647,706,000.00
$50,000,000.00
Revenue This Year
$14.20
N/A
Revenue Next Year
$6.82
N/A
P/E Ratio
$80.13
N/A
Revenue Growth
22.39
495.66
52 Week Low
$22.49
$9.83
52 Week High
$41.64
$19.00

Technical Indicators

Market Signals
Indicator
IIIN
KALV
Relative Strength Index (RSI) 28.19 56.35
Support Level $30.23 $14.59
Resistance Level $32.50 $17.30
Average True Range (ATR) 1.06 1.10
MACD -0.44 -0.04
Stochastic Oscillator 8.18 57.48

Price Performance

Historical Comparison
IIIN
KALV

About IIIN Insteel Industries Inc.

Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: